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Abstract
Background: Bovine leukemia virus (BLV) infection is omnipresent in dairy herds causing direct economic losses
due to trade restrictions and lymphosarcoma-related deaths. Milk production drops and increase in the culling rate
are also relevant and usually neglected. The BLV provirus persists throughout a lifetime and an inter-individual
variation is observed in the level of infection (LI) in vivo. High LI is strongly correlated with disease progression and
BLV transmission among herd mates. In a context of high prevalence, classical control strategies are economically
prohibitive. Alternatively, host genomics studies aiming to dissect loci associated with LI are potentially useful tools
for genetic selection programs tending to abrogate the viral spreading. The LI was measured through the proviral
load (PVL) set–point and white blood cells (WBC) counts. The goals of this work were to gain insight into the
contribution of SNPs (bovine 50KSNP panel) on LI variability and to identify genomics regions underlying this trait.
Results: We quantified anti–p24 response and total leukocytes count in peripheral blood from 1800 cows and used
these to select 800 individuals with extreme phenotypes in WBCs and PVL. Two case-control genomic association
studies using linear mixed models (LMMs) considering population stratification were performed. The proportion of
the variance captured by all QC-passed SNPs represented 0.63 (SE ± 0.14) of the phenotypic variance for PVL and 0.
56 (SE ± 0.15) for WBCs. Overall, significant associations (Bonferroni’s corrected -log10p > 5.94) were shared for both
phenotypes by 24 SNPs within the Bovine MHC. Founder haplotypes were used to measure the linkage disequilibrium
(LD) extent (r2 = 0.22 ± 0.27 at inter-SNP distance of 25−50 kb). The SNPs and LD blocks indicated genes potentially
associated with LI in infected cows: i.e. relevant immune response related genes (DQA1, DRB3, BOLA-A, LTA, LTB, TNF,
IER3, GRP111, CRISP1), several genes involved in cell cytoskeletal reorganization (CD2AP, PKHD1, FLOT1, TUBB5) and
modelling of the extracellular matrix (TRAM2, TNXB). Host transcription factors (TFs) were also highlighted (TFAP2D;
ABT1, GCM1, PRRC2A).
Conclusions: Data obtained represent a step forward to understand the biology of BLV–bovine interaction, and provide
genetic information potentially applicable to selective breeding programs.
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Background
The Bovine leukemia virus (BLV) is an oncogenic δ-
retrovirus that persistently infects cattle [1]. BLV infec-
tion elapses without noticeable symptoms in most of the
animals while 30–40% of them evolve into a sub-clinical
persistent lymphocytosis (PL) characterized by an expan-
sion of proviral infected B-lymphocytes in peripheral blood
increasing white blood cells (WBC) counts (leukocytosis).
Less than 10% of infected animals will develop the severe
form of the disease leading to lethal lymphomas or lym-
phosarcoma in various organs [2]. The BLV is transmitted
among cows through direct exposure to blood, body fluids
or consumption of contaminated colostrum/milk with pro-
viral DNA [3, 4]. In the absence of effective measures con-
trolling BLV transmission, the virus is massively propagated
reaching high levels of endemicity. BLV is world-wide
distributed. In North America BLV’s prevalence reached
70–85% at farm level [5–7], and in Argentina more than
80% of the lactating cows in the main dairy production
area are infected [8]. International trade restrictions of
livestock products from affected herds [9] impact on the
regional economy, but the total economic loss is signifi-
cantly higher if we consider milk production dropping
and faster culling of asymptomatic BLV carriers compared
to BLV free herds [10, 11]. These conditions are empha-
sised in lymphocytotics animals and also in those with
high anti-BLV humoral response [12–16]. Traditional con-
trol strategy implies segregating/eliminating infected cows
after BLV testing, but this is not economically affordable
when the regional prevalence is high [17]. A suitable long
term approach to contain endemic livestock diseases, es-
pecially those where the therapeutics or preventives treat-
ments failed, is DNA-based breeding for host resistance to
infection [18]. Mastitis incidence is currently being incor-
porated in genomic evaluations for dairy cattle ([19, 20]).
A key component to set up host genetic studies is properly
defining and recording a consistent phenotype [21, 22].
The high PVL has been associated with progression of the
BLV pathogenesis [23, 24], and with enhanced viral dis-
semination [25]. Previous evidence pointed to DNA
polymorphisms in candidates genes (in particular, al-
leles from the bovine MHC class II DRB gene) as con-
tributors to the inter-individual variation in the PVL
and PL [26–34]. However, genetic variation for resist-
ance/susceptibility to diseases in cattle is usually poly-
genic, i.e. susceptibility to paratuberculosis [35, 36],
mastitis [37, 38] bovine respiratory disease complex
(BRDC) [39] and recently observed in a genome-wide
mapping for genetics determinants of BLV incidence
[40, 41].
With the final objective in mind of developing (imple-
menting) genomics selection programs to control BLV
dissemination it is essential to understand the biological
mechanism implicated. In an attempt to address this
questions we utilized antibodies anti-p24 as cost-effective
predictors of the level of PVL in blood [8] on over 1800
animals, characterized with WBC counts, in order to re-
cruit a population of Holstein and Holstein x Jersey cross-
bred dairy cows representing extreme phenotypes of level
of infection (LI) in vivo, and therefore, with different indi-
vidual risk for viral transmission. Afterwards, we integrate
these phenotypes in a case-control genome-wide associ-
ation study (GWAS) using the Illumina BovineSNP50v2




Blood samples were obtained from 1800 Holstein and
Holstein x Jersey cows representing 25 half-sisters
families from 16 dairy herds located in the central region
of Argentina. Farm owners’ consent was obtained before
animal sampling. All animals have full pedigree and were
over 3 years old at the time of sampling and between 1st
and 9th lactation (78.7% concentrated between 2nd and 4th
lactation). The procedures followed for extraction and
handling of samples were approved by the Institutional
Committee for Care and Use of Experimental Animals
of the National Institute of Agricultural Technology
(CICUAE-INTA) under protocol number 35/2010, and
followed the guidelines described in the institutional
Manual. Blood samples were collected in heparinized
tubes. Plasma and fresh blood were frozen at − 20 °C
until used.
Quality and concentration of genomic DNA extracted
from whole blood samples using a commercial kit (Blood
Genomic DNA AxyPrep™, Axygen Biosciences, Union City,
USA) was assessed using a micro−volume spectropho-
tometer (NanoDrop™ Technologies, Inc. Wilmington,
USA). DNA samples were normalized to a minimum
concentration of 20 ng/μl.
Phenotyping
The anti-p24 ELISA assay was used to discriminate BLV
infected animals [42], followed by total WBC counts. In
a previous study we showed that the individual anti-BLV
humoral response is a cost effective indirect measure of
infection in vivo [8]. Therefore, animals were first screened
by anti-p24 ELISA and then divided into two groups of
contrasting phenotypes on the basis of their antibodies
level. The LI in selected animals was then corroborated by
determining blood PVL set-point.
Serology: The recombinant viral core-p24 protein was
used to detect plasma anti-BLV antibodies for each sample
as described in [42] Briefly, a ratio sample to positive (S/P),
called % of reactivity (% R) is obtained: S/P = [(ODSample -
ODWS-)/(ODWS+ 1/7 - ODWS-)] × 100, where OD= optical
density, WS- = negative serum, WS + 1/7 = serum
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international standard weak positive control (diluted 1:7
in negative serum) used as reference value. The % R of all
samples tested was indicated as “low” (LR), for records
between a cut-off value (25%) [42] and the weak positive
serum value (100%); and as “high” (HR) in those samples
with measurements higher than 200%.
PVL relative quantification: PVL determination was
performed over LR and HR animals by real-time PCR
using TaqMan technology as described in [42, 43]. A
fragment of BLV pol gene (target) was amplified simultan-
eously with the reference gene 18S. Fetal Lamb Kidney
cells (FLK) containing 4 copies/cell of BLV proviral DNA,
in a final concentration of 1% in BLV-free peripheral blood
mononuclear cells (PBMCs) were used as internal control.
This proportion of BLV-infected cells corresponds to a
low level of natural infection [42], proved to be 5% in aleu-
kemics animals [44]. The relative PVL was defined accord-







where E = reaction efficiency; Ct = threshold cycle. The
control PVL was indicated as 1 and all samples tested
were referred to this. The detection limit was 1 infected
cell /2000 uninfected cells. The PVL was qualified as
“No Detectable” (ND) if a Ct value could not be obtained
(below the detection limit), as “low” if R < 1 (LPVL) and as
“high” if R > 1 (HPVL).
WBC counts: Total leukocyte count was performed
manually using a haemocytometer. Fresh blood was
diluted 1:20 in a 1% Gentian Violet and 2% acetic acid
solution. Normal WBC counts in BLV-seronegative
adult cattle are in the range of 2100 to 11,500 cells/μl
(mean: 6800 ± 2 SD) [46].
Genotyping with the medium density SNPs chip
A total of 970 cows with PVL determination (74%
Holstein and 26% Holstein x Jersey), and 29 bulls (24
Holstein and 5 Jersey) where chosen for genotyping.
SNP genotyping was performed by GeneSeek (Neogen
Corporation Company, Lincoln, NE, USA) using the
BovineSNP50 v2 BeadChip. The panel tests 54,609 SNPs
spaced 49.4 kb on average (median spacing of 37 kb) [47].
SNPs were mapped to the bovine assembly UMD 3.1 [48].
The SNPs identification was reassigned to its correspond-
ing “rs” catalogued in dbSNP [49] using the SNPchiMp v.3
tool [50].
Quality control (QC) of the genotypic data was carried
out using a set of tools and routines provided by PLINK
v1.07 [51]. Individuals with a genotype call rate (CRIND) <
90% were excluded from further analysis. Mendelian in-
heritance discordances were checked and set as missing.
SNPs with a call rate (CRSNPs) < 90%, a deviation from
HWE p < 1.10− 08 and Minor Allele Frequency (MAF) <
0.01 were removed from the study. After the QC, the data
set was composed of 44,174 SNPs and 925 individuals
(898 cows and 27 bulls).
Case-control definitions
The case-control phenotypes to conduct GWAS for LI
in vivo considered 396 cases (HPVL) and 373 controls
(ND/LPVL). The alternate phenotype was defined by the
number of circulating white blood cells (WBCs), which
is indicative of the presence of PL, a sub-clinical symp-
tom of BLV infection [52], clustering 283 cases (WBC ≥
11,500 cells/μl) and 611 control cows (WBC < 11,500
cells/μl).
Linkage disequilibrium
We performed chromosomal haplotypic phase assignment
using the software DualPHASEv1.1 included in the PHA-
SEBOOK 2.3 package [53] using the default settings. To
calculate the extent of linkage disequilibrium (LD) only ma-
ternal founders chromosomes were used. Phasing algo-
rithms allowed the imputation of not assigned genotypes
[54] so that the missing genotypes or those set as missing
due to Mendelian inconsistencies were imputed. Measure
of LD extent was addressed by calculating the correlation
of alleles in two loci (r2 and D’) for each chromosome with
Haploview v4.2 [55]. The calculations were performed on
all pairs of syntenic SNPs with an inter-marker distance <
1 Mb. The r2 measure was then averaged at intervals of
10 kb and plotted versus the inter-SNPs distance.
Population stratification
We inspected the genealogy of bulls in the sampled
families (http://www.sra.org.ar/rrgg/) evidencing a strong
co-ancestry among them (Additional file 1: Figure S1). In
order to prevent spurious associations due to population
substructure we performed a multi-dimensional scaling
(MDS) analysis on identity by state (IBS) pairwise based
distances matrix as implemented in PLINKv1.07 [51]: 1
− (IBS2 + 0.5IBS1)/N, where IBS2 is the number of SNPs
in which two individuals share two IBS alleles; IBS1 is the
number of SNPs in which only one allele is shared IBS
and N is the number of markers used. Finally, the distance
matrix was partitioned into a number of uncorrelated var-
iables (or Principal Components, PC). The first two PCs
were used to visualize differences in ancestry among indi-
viduals (Additional file 2: Figure S2).
Association analysis
The GWAS were performed using LMMs as implemented
in GCTA v1.24 [56]. The general model in the observed
scale can be written as:
y ¼ Xbþ Zuþ e
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where y is a vector n × 1 that contains binaries values
for PVL or WBC; b is a vector that contains the fixed ef-
fects of the SNPi to be tested for association (considering
an additive genetic effect) and the co-variables Age (Aj)
(j = 3 to 12); Herd (Hk) (k = 1 to 16); Lactation Number
(Ll) (l = 1 to 9); Percentage of Holstein breed (PHm)
(m = 0, 0.125, 0.25, 0.50, 0.75 and 1); Bull (Bn) (n =
1 to 25) and PC derived from the co-ancestry analysis
(PC1 – PC8). The random effects included the additive
polygenic effect u of the animal; and the vector e of resid-
uals effects, X and Z stand for the incidence matrix that
relate the values in y to the fixed effects in b and the ran-
dom effects in u, respectively. A liability threshold model
l =Xb + g + e was utilized in order to relate observations
on the observed scale to liabilities on the unobserved con-
tinuous scale. Liability phenotypes are distributed as
~N(0,1), On the liability scale, the random effects included
the additive polygenic effect g of the animal, distributed
~N(0, σg2G), where G represents the genetic relationship
matrix (GRM) calculated from the proportion of shared
alleles among individuals for all QC-passed SNPs; and the
vector e of residuals effects, distributed ~N(0, σ e2I )),
where I is the identity matrix. Other terms are the same as
in the linear model but on the liability scale [57, 58]. The
heritability on the scale observed ðh2 ¼ σ2uσ2uþσ2εÞ was trans-




where h2l is the heritability on the underlying scale; h
2
o is
the heritability on the observed scale; K is the disease
prevalence and zis the height of the density function of
the standard normal probability at the threshold value (K).
This model was utilized to calculate the genetic correl-
ation between PVL and WBC. According to Lee et al.





K2ð 1−K2Þ covðg1; g2Þ ; where, gis the genetic
value on the observed scale, g∗ is the genetic value on
the underlying scale, z is the height of the density func-
tion of the standard normal probability at the threshold
value (K), P is the proportion of cases in the sample and
K is the prevalence for features 1 (PVL) and 2 (WBC),
respectively.
The association analysis implemented in GCTA v1.24
uses the restricted maximum likelihood method (REML)
to solve the equations of LMMs [56, 57].
The genetic variance for PVL and WBCs traits was calcu-
lated on the 29 individual autosomes and on the X bovine
sexual chromosome. The genetic variance was decomposed





where, gi is a random genetic effects vector corresponding
to the complete genome or a particular chromosome. The
phenotypic variance was partitioned so that varðyÞ
¼ Pri¼1 σ2i G + σ2i I where σ2i is the variance of the i-th
genetic factor with its related GRM.
The family-wise error rate was controlled by Bonferroni’s
correction α′ ≈ α/n, where α is the significance level of 5%
and n is the number of SNPs tested. The α′value represents
the threshold that the p-value must reach for each test to
be considered significant.
Gene content of the genomic regions identified in the
association studies
Gene annotation for BTA 23 (UMD3.1 bovine assembly,
[48]) was retrieved using BioMart tools [60]. Firstly, SNPs
were assigned to a particular gene if they were located on
exons, introns or untranslated regions (UTRs). Secondly,
SNPs lying within a 20 kb window upstream and down-
stream from gene boundaries, aiming to capture promoter/
expression regulatory regions [61]. Finally, remaining SNPs
were assigned to the closest gene from 20 to 30 kb,
within the range of useful average LD values found
(r2 > 0.2) [62–65]. Gene to SNPs mapping was per-
formed using BedTools package [66]. Gene functional
classification based in Gene Ontology terms (GO) was
performed using the PANTHER classification system
website (http://www.pantherdb.org/) [67].
Results
Genome-wide distributed SNPs were tested for associ-
ation with both PVL and WBCs traits using logistic re-
gressions assuming an additive model that incorporated
as covariates 8 PCs and other confounding factors Age
(A); Herd (H); Lactation number (L); Percentage of Hol-
stein (PH) and Bull (B). The observed statistical values
of association were ordered from lowest to highest and
plotted against their expected values and genomic infla-
tion factor (λ) was calculated using PLINK. Both for
PVL (Additional file 3: Figure S3, λ = 1.21) and WBCs
(Additional file 4: Figure S4, λ = 1.30), the data was best
fitted with models considering PCs1–8 + A_H_L_PH_B.
Given that kinship and/or cryptic relationship might be
contributing sources of distortion in the case-control as-
sociations we decided to use LMMs as implemented in
GCTA v1.24 [56] that incorporates each of QC-passed
SNP as a fixed effects and the polygenic animal effect as
random. QQ plots showed a proper fit for stratification
and a pronounced deviation to the right, which is sug-
gestive of true associations (Fig. 1).
In parallel, genome-wide regression methods incorporat-
ing GRM allowed to estimate the fraction of phenotypic
variance captured by the common SNPs in the genotyping
panel. The heritability (h2) for PVL was estimated at 0.63
(SE ± 0.14) on the scale of liability, with a prevalence of 40%
of cows with high PVL. A h2lia = 0.56 (SE ± 0.15) to equal
prevalence was estimated for a phenotype corresponding to
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a high WBCs count (> 11,500 cells/μl). Polymorphisms in
only three chromosomes explained more than 5% of the
phenotypic variation for PVL: Bos taurus autosome (BTA)
10 7.1% (SE ± 5.0%), BTA 11 5.8% (SE ± 4.1%) and BTA 23
30.6% (SE ± 7.8%). Similarly, when considering the percent-
age of variation in WBCs, BTA 11 12.4% (SE ± 6.5%), BTA
21 5.4% (SE ± 5.0%) and BTA 23 24.0% (SE ± 7.2%) auto-
somes accounted for 74% of the total variance explained by
all SNPs (58%).
The Manhattan plots revealed significantly associated
SNPs with HPVL in peripheral blood (Fig. 2) and with a
high number of circulating WBCs (Fig. 3).
All SNPs exceeding the significance threshold after
Bonferroni’s correction (−log10p > 5.94) are located on
BTA 23. Notably, SNPs mapping on BTA 23 largely cap-
tured most of the genetic variation for both traits, influ-
encing BLV levels of infection. Overall, a group of 24
SNPs were significantly associated with high PVL, whilst
11 SNPs were associated to high WBCs counts. Of these,
only 1 SNP (rs110277740) is not shared with those asso-
ciated with PVL (Table 1). PVL and WBCs are corre-
lated (~ 0.81 (SE ± 0.10)). Joint significant positions for
PVL and WBCs taken together delimit a region on BTA
23 that is located within the bovine MHC, approximately
from the beginning of bovine leukocyte antigen (BoLA)
class IIa region (~ 20.6 Mb) extending to the Histone
cluster I which mark off the end of the complex (~
33.3 Mb). Only a small fraction of phenotypic variance
a b
Fig. 1 QQ plots. pobs vs pexp obtained from the association mapping using LMMs of 44,174 SNPs for a) PVL and b) WBCs
Fig. 2 Manhattan plot depicting GWAS results of BLV level of infection
using LMMs for PVL. The -log10(p) values for each SNP association is
represented for each chromosome (BTA) and location within it. The SNPs
exceeding the significance threshold according to Bonferroni’s correction
(−log10(p) > 5.94, blue horizontal line) are highlighted in green
Fig. 3 Manhattan plot depicting GWAS results of BLV level of
infection using LMMs for WBCs. The -log10(p) values for each SNP
association is represented by chromosome (BTA) and location within
it. The SNPs exceeding the significance threshold according to
Bonferroni’s correction (−log10(p) > 5.94, blue horizontal line) are
highlighted in green
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is explained by SNPs located outside this MHC region,
so we decided to repeat the GWAS for PVL but exclud-
ing the SNPs located between ~ 20–36 Mb of BTA 23,
which could be masking the SNPs effects in non-MHC
regions. As result, we did not find any significantly asso-
ciated SNP (Additional file 5: Table S1).
Unless a significant SNP is itself the causal variant,
it will capture the effects of other variants in LD re-
sponsible for the phenotype. The clustering of genes
with related functions in the linkage disequilibrium
pattern in the bovine MHC region makes it difficult to
detect effects of individual loci. We characterized the
LD extent (Additional file 6: Figure S5) in our Holstein
and Holstein x Jersey population. At distances ≤30 kb,
the average correlation value r2 was 0.26 ± 0.30 (34%
of pairwise SNPs showed r2 > 0.25). This value rapidly
decays to 0.14 ± 0.21 when the inter-markers distance
was between 50−100 kb. About 60% of the inter-SNPs
distances in this work is in the range of 25–50 kb with
an average r2 = 0.22 ± 0.27, indicating that causal gen-
etics variants effects could be retrieved from SNPs
hits.
We found five significantly associated SNPs pairs having
a strong allelic correlation (r2 > 0.80). The rs110579760
(BTA23: 25,507,676 bp) was in LD with rs109343703 (r2 =
0.95; BTA23: 24,699,202 bp) and rs110499907 (r2 = 0.88;
BTA23: 24,727,613 bp). The r2 between rs109343703
and rs110499907 was 0.90. The remaining pairs were
rs41255514 (BTA23: 27,305,227 bp) and rs17872223
(BTA23: 27,306,795 bp) with r2 = 0.96, and the pair
rs110794231 (BTA23: 27,887,914 bp) and rs41587536
(BTA23: 27,923,154 bp) had the same r2 value. Figure 4
shows the gene context and the LD map in the BTA23:
24,872,758–29,535,762 bp region.
Table 1 Significantly associated variants in the GWA studies based on MLMs
refSNP_ID BTA PVL WBC Positionc
ba SD pb ba SD pb
rs110155623 23 −0.5 0.10 7.20 × 10− 07 −0.44 0.09 6.23 × 10− 07 20,692,320
rs41587216 23 −0.15 0.03 5.06 × 10− 07 −0.13 0.03 4.95 × 10− 07 22,300,959
rs41566363 23 −0.18 0.03 1.97 × 10− 07 −0.15 0.03 5.53 × 10− 07 22,997,898
rs41641297 23 0.21 0.03 2.80 × 10−10 0.15 0.03 5.19 × 10− 08 24,181,053
rs109343703 23 0.24 0.04 1.95 × 10− 08 – – – 24,699,202
rs110499907 23 0.21 0.04 1.96 × 10− 07 – – – 24,727,613
rs110473048 23 0.21 0.03 1.78 × 10−12 0.14 0.03 9.97 × 10−08 25,109,188
rs110525467 23 −0.36 0.04 5.32 × 10−16 −0.24 0.04 5.90 × 10−10 25,426,985
rs110579760 23 0.25 0.04 3.66 × 10−09 – – – 25,507,676
rs110836188 23 0.23 0.04 6.50 × 10−11 – – – 27,088,825
rs41255514 23 0.23 0.03 1.47 × 10−11 – – – 27,305,227
rs17872223 23 0.22 0.03 6.99 × 10−12 – – – 27,306,795
rs110861313 23 0.19 0.03 7.02 × 10−11 0.12 0.02 5.70 × 10−07 27,444,064
rs17871874 23 0.17 0.03 2.69 × 10−07 0.15 0.03 1.96 × 10− 07 27,485,467
rs110260956 23 0.21 0.04 7.70 × 10−07 – – – 27,545,231
rs110350951 23 0.14 0.03 1.54 × 10−07 – – – 27,841,983
rs110794231 23 −0.16 0.03 6.44 × 10− 09 – – – 27,887,914
rs41587536 23 −0.15 0.03 2.25 × 10− 08 – – – 27,923,154
rs110742604 23 −0.26 0.03 6.67 × 10−14 −0.16 0.03 8.18 × 10− 08 28,087,630
rs109856572 23 −0.18 0.03 1.27 × 10− 08 −0.14 0.03 1.72 × 10− 07 28,649,349
rs110769723 23 −0.25 0.04 3.01 × 10− 08 – – – 29,285,952
rs109015676 23 −0.21 0.04 4.82 × 10− 07 – – – 29,535,762
rs110034224 23 −0.18 0.04 5.46 × 10− 07 – – – 30,662,593
rs110277740 23 – – – −0.19 0.03 2.20 × 10− 08 31,286,064
rs109754326 23 −0.15 0.03 2.99 × 10− 07 – – – 33,296,630
Abbreviations: refSNP_ID: SNP Identification based on dbSNP (http://www.ncbi.nlm.nih.gov/SNP/), PVL: proviral load, WBC: whole blood cells counts, SD:
standard deviation
aSNP effect size (β of regression)
bp-value: Under null hypothesis, probability of obtaining the observed effect size
cSNP location according to bovine genome assembly UMD3.1
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SNPs were assigned to putative biological function if
they fell within a coding, intronic, or regulatory region. For
those SNPs mapping outside genic regions we scrutinised
the closest gene located at a distance where a moderate LD
was kept. A total of 44 genes were identified using the cri-
teria described above. Table 2 details the genomic context
of each SNP (position and related genes). Half of significant
SNPs mapped to putative regulatory regions, 24% to inter-
genic regions, 12% to introns and 12% of SNPs to exons.
Only one SNP (rs41255514) is located in a 3′-untranslated
region (3’-UTR). The SNP with the lowest p-value for
both conditions was rs110525467 (pPVL = 5.32 × 10
− 16
and pWBC = 5.90 × 10
− 10) introducing a synonymous
substitution in the MHC class II gene BoLA-DQA1
(ENSBTAG00000037605) located in BTA23: 25,426,330–
25,430,097 bp. The remaining 10 positions associated with
a high number of peripheral blood leukocyte counts in-
cluded an intronic SNP located in the Polycystic kidney and
hepatic disease 1 gen, (PKHD1 - ENSBTAG00000011237)
and a synonymous substitution in the Proline-rich coiled-
coil 2A gene (PRRC2A - ENSBTAG00000019682). In
addition, six SNPs significantly associated with this
condition were located in regulatory regions of the
GPR111 (ENSBTAG00000037687), CD2AP (ENSBTAG
00000000322), TFAP2D (ENSBTAG00000020425), C23
H6ORF47 (ENSBTAG00000023628), ABHD16A (ENS
BTAG00000000578), LY6G5C (ENSBTAG00000025
449), LY6G5B (ENSBTAG00000039740), CSNK2B (ENS
BTAG00000008837), BAT4 (ENSBTAG00000008835),
APOM (ENSBTAG00000008833), BAG6 (ENSBTAG0
0000019685), TUBB5 (ENSBTAG00000006969), IER3
(ENSBTAG00000011358), FLOT1 (ENSBTAG00000009
960), TRIM31 (ENSBTAG00000004490), TRIM40 (ENS
BTAG00000037381) and ABT1 (ENSBTAG00000010
784) genes (Table 2). The two remaining SNPs, rs41587216
and rs110473048, were at 39.3 kb of CRISP1 (ENSBTA
G00000008085) and 21.7 kb GCM-1 (ENSBTAG0000000
8148), respectively.
The PVL phenotype association study included all sig-
nificant SNPs for the GWAS considering WBCs -except
the SNP assigned to Activator of Transcription Basal 1
gene (ABT1, rs110277740) - and other 14 significant
SNPs. The functional annotation resulted in a synonym-
ous substitution in TNXB (ENSBTAG00000001444) and a
SNP located in the 3’-UTR region of SCL44A4 (ENSBT
AG00000005675). Also, there are two SNPs located in in-
tronic regions of NEU1 and TRAM2 (ENSBTAG000
00009112 and ENSBTAG00000005674, respectively). The
Fig. 4 Gene context and LD map of the bovine chromosome 23 containing the SNPs significantly associated in the GWAS. A) BTA23:24,872,758–
29,535,762 bp. ■ PVL significant SNPs; red square symbol: WBCs significant SNPs; ——— log10(p)_PVL; red broken line: log10(p)_WBC; MAF:
Minimum Allele Frequency. Local LD map estimates (D´) based on 235 SNPs located within the cattle MHC region in founder maternal
chromosomes. Triangles delimited with black lines identify haplotype blocks derived from Haploview [55]. The gene content of the region
according to the bovine genome assembly UMD3.1 was obtained from Ensembl Genome Browser (http://www.ensembl.org). Red vertical bars
indicate SNPs of the SNP50K chip located in the region
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variant rs110260956 is 20 kb upstream or downstream of
the following genes: LTA (ENSBTAG00000000016), NF
KBIL1 (ENSBTAG00000014492), ATP6V1G2 (ENSBTA
G00000014491), LTB (ENSBTAG00000020674) and TNF
(ENSBTAG00000025471), while rs110350951 meets the
same condition in U6 snRNA (ENSBTAG00000043004)
and Ig-like MHCI genes (ENSBTAG00000007075), and
rs109754326 in NRSN1gene (ENSBTAG00000009180).
Three SNPs significantly associated with high PVL are
present in putative regulatory regions of 7 genes encoding
Table 2 Genes linked to SNPs identified in the GWA analysis for PVL and WBCs
refSNP_ID Positiona A1b MAF Variant typec Symbold Description
rs110155623 20,692,320 A 0.03 Regulatory intergenic GPR111, CD2AP G protein-coupled receptor 111; CD2-associated protein
rs41587216 22,300,959 A 0.46 Intergenic CRISP1 Cysteine-rich secretory protein 1
rs41566363 22,997,898 C 0.33 Regulatory intergenic TFAP2D Transcription factor AP-2 delta (activating enhancer
binding protein 2 delta)
rs41641297 24,181,053 A 0.40 Intronic PKDH1 Polycystic kidney and hepatic disease 1
rs109343703 24,699,202 A 0.12 Intronic TRAM2 Translocation associated membrane protein 2
rs110499907 24,727,613 A 0.14 Intergenic TRAM2 Translocation associated membrane protein 2
rs110473048 25,109,188 A 0.34 Intergenic GCM-1 Glial cells missing homolog 1
rs110525467 25,426,985 G 0.19 Synonymous substitution BOLA-DQA1 Major histocompatibility complex, class II, DQA1
rs110579760 25,507,676 G 0.12 Intergenic BOLA-DRB3 Major histocompatibility complex, class II, DRB3
rs110836188 27,088,825 G 0.21 Synonymous substitution TNXB Tenascin-X precursor
rs41255514 27,305,227 G 0.34 3′-UTR SCL44A4 Solute carrier family 44, member 4
rs17872223 27,306,795 G 0.33 Intronic NEU1 Sialidase 1 (lysosomal sialidase)
rs110861313 27,444,064 C 0.46 Regulatory intergenic C23H6ORF47, ABHD16A,
LY6G5C, LY6G5B, CSNK2B,
BAT4, APOM, BAG6
Chromosome 23 open reading frame, human C6orf47;
Abhydrolase domain containing 16A; Lymphocyte
antigen 6 complex, locus G5C; Lymphocyte antigen 6
complex, locus G5B; Casein kinase 2, beta polypeptide;
G patch domain and ankyrin repeats 1; Apolipoprotein
M; BCL2-associated athanogene 6
rs17871874 27,485,467 A 0.24 Synonymous substitution PRRC2A Proline-rich coiled-coil 2A
rs110260956 27,545,231 G 0.15 Regulatory intergenic LTA, NFKBIL1,
ATP6V1G2,LTB,TNF
Lymphotoxin alpha; Nuclear factor of kappa light
polypeptide gene enhancer in B-cells inhibitor-like 1;
ATPase, H+ transporting, Lysosomal 13 kDa, V1 subunit
G2; Lymphotoxin beta; Tumor necrosis factor
rs110350951 27,841,983 G 0.44 Regulatory intergenic U6, Ig_like_MHC_I U6 small nuclear RNA; Major histocompatibility complex,
class I, A-like
rs110794231 27,887,914 A 0.38 Intergenic BOLA Bola class I
rs41587536 27,923,154 G 0.38 Intergenic SFTA2 Surfactant associated 2
rs110742604 28,087,630 G 0.20 Regulatory intergenic TUBB5, IER3, FLOT1 Tubulin, beta class I; Immediate early response 3;
Flotillin 1
rs109856572 28,649,349 A 0.41 Regulatory intergenic TRIM31, TRIM40 Tripartite motif containing 31; Tripartite motif
containing 40
rs110769723 29,285,952 G 0.18 Regulatory intergenic LOC516273, LOC618064,
LOC785162
Olfactory receptor; Olfactory receptor; Olfactory receptor
rs109015676 29,535,762 G 0.12 Regulatory intergenic LOC784787,LOC511103,
LOC784858
Olfactory receptor; Olfactory receptor; Olfactory receptor
rs110034224 30,662,593 C 0.17 Regulatory intergenic LOC522315 Olfactory receptor
rs110277740 31,286,064 G 0.17 Regulatory intergenic ABT1 Activator of basal transcription 1
rs109754326 33,296,630 G 0.34 Regulatory intergenic NRSN1 Neurensin 1
Abbreviations: refSNP_ID: dbSNP SNPs Identification (http://www.ncbi.nlm.nih.gov/SNP/), MAF: Minor Allelic Frequency, NA: Not Applicable
aSNP location according to bovine genome assembly UMD3.1
bAllele with the lowest frequency in the 50KSNP chip according to the Illumina nomenclature TOP/BOT
cIntergenic: SNP positioned between 20 and 55 kb to the nearest gene; Regulatory intergenic: SNP positioned 0-20Kb upstream or downstream of a gene;
Synonymous substitution: exonic SNP producing a synonymous amino acid substitution in the gene; 3’-UTR: SNP positioned in the 3′ untranslated region of a
gene; Intronic: SNP positioned in gene introns
dGene symbol according to UniProtKB (http://www.uniprot.org/)
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Odorant receptors (Olfactory receptor). Finally, rs11
0579760, rs110794231 and rs41587536 polymor-
phisms are at 30.7, 20.3 and 22.3 kb of BoLA-DRB3
(ENSBTAG00000013919) BoLA-A (ENSBTAG00000
022590) and SFTA2 (ENSBTAG00000038810), respect-
ively. Genes represented by the SNPs were assigned to
Gene Ontology (GO) functional terms and the PANTHER
(Protein Class, PC) (http://pantherdb.org/) classification
system. The analysis was performed for all genes repre-
sented by significantly associated SNPs with any of the
two traits. A total of 11 PC “parents” terms were identi-
fied being the three most common categories “protein
defense/immunity”, (PC00090) (21,7%), “signalling mol-
ecule” (PC00207) (21,7%) and cytoskeletal protein
(PC00085) (8,7%). In Additional file 7: Table S2 a de-
scription of each PC term is displayed along with their
“child” terms providing specificity to the functional descrip-
tion. Notably, a single gene might be contained in more
than one PC class. Afterwards, we classified genes under
the category GO “Biological Processes” (BP) wherein each
gene identification is assigned according to their function
within a network of proteins that collectively carry out a
particular process within the cell. Figure 5 presents the dis-
tribution of 12 “parent” terms found according to GO BP
classification, these represent general cellular processes be-
ing the top five terms “immune system process” (16%), “re-
sponse to stimulus” (16%), “metabolic process” (14%),
“cellular process” (12%) and “localization” (11%). The
search for GO terms and/or KEGG pathways overrepre-
sented on the gene set identified vs those present in whole
bovine gene set using FatiGO method [68] did not produce
significant results (data not shown).
Discussion
The humoral immune response plays a crucial role in
the control of viral infections in cattle and humans, and
the level of response varies from individual to individual,
being this variability highly heritable [69, 70]. In cattle,
we showed that the humoral response to BLV infections
indeed varies among animals and, interestingly, it can be
used to infer the circulating PVL in an infected animal
[8]. In this study, we use the % of Reactivity (anti-p24)
to screen a population of BLV naturally infected animals
aiming to select cows most likely to have extreme values
of PVL set-point, which was subsequently confirmed by
qPCR. The predictive ability of serological markers to
detect high PVL conditions was good being the ROC
area under the curve > 0.80 (data not shown). We then
performed a case-control study setting levels of infection
(LI) as phenotype aiming to estimate (a) the proportion
of phenotypic variation that can be attributed to gen-
etic components and (b) the cattle genome mapping
positions of genetic polymorphisms underlying this
variation. A positive genetic correlation between PVL
and WBCs of magnitude ~ 0.81 (SE ± 0.10) supports
the idea of shared or genomic regions influencing
both traits.
We used kinship captured from QC pruning variants
to assess the additive genetic variance of LI produced by
BLV in the population. The percentage of variation reached
was 63% (h2GRM_PVL = 0.63) and 56% (h
2
GRM_WBC = 0.56) on
the risk scale or liability. On this scale, the phenotypic
variances do not depend on the disease prevalence, so
h2lia values allow comparisons between populations and
environments where incidence varies. When partitioned,
Fig. 5 Distribution of the GO “Biological Process” (BP) categories for genes represented by the significantly associated SNPs in GWAS for PVL and
WBC counts
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the proportion of the phenotypic variance explained by
markers for both phenotypes was distributed on different
chromosomes. In a pedigree-based study by Abdalla et al.
[71], the contribution of genetic components to the in-
cidence of BLV in Holsteins and Jersey herds (approxi-
mately 30% of herd level prevalence) was estimated to
be 8%, showing that environmental factors could play a
major role over genetics in susceptibility to BLV occurrence.
Paradoxically, the implementation of good veterinary
practices and proper management in order to reduce
iatrogenic issues, considered one of the main factors of
infection among cows within herds [44], failed to re-
duce the prevalence ([7, 43]). However, we focused on
phenotypes representing the BLV level of infection in
cows. The LI is directly related to the cows’ viral trans-
mission ability to BLV free herd mates. Methods in-
corporating GRM as used in this study, have been
successfully tested in selective breeding of animals and
plants for complex traits [72, 73] and proposed to pre-
dict human disease phenotypes [74–76]. The high herit-
ability values obtained for LI have remarkable practical
implications in genetic improvement programs aiming to
reduce the dissemination of BLV in heavily infected popu-
lations. Sources of non-additive genetic variance, such as
dominance or epistasis among markers, were not consid-
ered in this study; however, the evidence indicates that the
additive genetic variance is the major contributor to the
phenotypic variance in complex characters [77–79]. To
our knowledge, this is the first report that estimates the
level of phenotypic variation in PVL and WBC explained
by SNPs markers in BLV infected animals.
The molecular basis influencing the inter-individual
difference in LI in vivo during aleukemic phase remains
unexplained. The mechanisms of BLV infection involve
an infectious cycle after a primary infection, where the
virus replicates and spreads within the host [80] by cell-
to-cell virion transference, but this process is promptly
abrogated by the anti-BLV host immune response [81].
Subsequently, the PVL is maintained by polyclonal ex-
pansion of surviving infected B-cells elapsed by mitotic
division where viral factors hijack host cellular physio-
logical pathways.
To evaluate which genes might be influencing the
set-point of PVL and WBC counts, we identified gen-
omic regions harbouring significantly associated SNPs
(p < 1.13 × 10− 6). These SNPs were located in the MHC
region on BTA 23, the most relevant gene cluster of the
immune sub-genome with high gene density and excep-
tional diversity.
Polymorphisms in the MHC loci −featured by an intricate
structure of linkage disequilibrium [82–85]− are associated
with viral infections outcomes, such as HIV-1, HBV, HCV
and HPV [86–88]. Fellay et al. [89, 90] confirmed through
GWAS that polymorphisms in HLA are leading host
genetic determinants on the viral load set-point in HIV−1
infected individuals. To investigate whether effects in others
loci were masked by the BoLA region, we have also per-
formed the same genome-wide analysis with the PVL level
but excluding SNPs within the bovine MHC. No tested
SNP reached significance level (Additional file 5: Table S1).
However, when BLV incidence (based on ELISA test) was
considered as phenotype for GWAS in US Holstein and
Poland Holstein-Frisian populations, many genes outside of
the MHC appears to be modulating this trait [40, 41].
The phenotype evaluated in these studies (BLV-seronega-
tives vs BLV-seropositives cows) indicated novel poten-
tially associated genomic regions, however they do not
corroborate previous finding suggesting the MHC as the
main genomic region harbouring genes influencing BLV
infection [28, 31, 33].
Genomic positions highlighted by GWAS emphasised
the potential influence of polymorphic variants in MHC
class I and II genes related to their central role in cell-
mediated immunity. Four SNPs shared the functional term
antigen processing and presentation (GO:0019882). The SNP
with the lowest p-value for both conditions studied was
rs110525467 (pPVL = 5.32 × 10
− 16 and pWBC= 5.90 × 10
− 10)
producing a synonymous substitution in the MHC class II
gene BoLA-DQA1. The rs110579760 (pPVL = 3.66 × 10
− 09)
located 30.7 kb downstream BoLA-DRB3 was significantly
associated with PVL, but not with WBC (Table 1). After
infection, a strong cytotoxic T-cell response is devel-
oped in peripheral blood against specific viral epitopes
[91]. In this regard, two significantly associated SNPs in
strong LD (r2 = 0.96) were functionally related with
BoLA−A and SFTA2 (Surfactant Associated 2) genes. The
magnitude of the immune response to viruses exerted by
CD8+ T cells and its association with polymorphisms in
HLA class I molecules is widely described in the literature
[92–94]. In the case of BLV infections in cattle, previous
studies have identified associations between polymorphisms
in MHC class I genes and resistance to PL in different
breeds [26, 27, 95, 96]. The closest SNP (rs110794231) to
BoLA-A is 35.2 Kb away corresponding to the SFTA2
gene. The SFTA2 gene encodes a secreted hydrophilic
protein with surfactant properties with a role in host
defence pathogen recognition patterns (bacteria, viruses
and fungi) [97, 98].
The SNP rs41587216 (pPVL = 5.06 × 10
− 07 and pWBC =
4.95 × 10− 07) was positioned in the secreted protein
CRISP1 (Cysteine-rich secretory protein 1), expressed in
skeletal muscle, salivary/lacrimal glands and during
lymphoblast development [99] potentially interfering in
innate and adaptive immunity (GO:0002376 “immune sys-
tem process”). Other GWAS hit, the SNP rs109856572, is
involved in biological processes that are associated with anti-
retroviral innate immunity. It is located in a transcriptional
regulatory region of TRIM31 and TRIM40 genes that pertain
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to the E3 ubiquitin ligases protein family [100–103]. Perhaps
the most studied TRIM mechanism is the restriction of in-
fections caused by HIV−1 exerted by TRIM5α [104–106].
A particular haplotype block located in the MHC Class
III region, encompasses a number of genes with a pleth-
ora of biological effects that may explain the associations
detected (Fig. 4). These genes play relevant roles in the
immune response, specifically in the regulation of apop-
tosis and proteasome degradation (LTA, TNF, BAG6)
[107], HIV−1 progression (BAT1–5, LY6) [86], T cells re-
sponse to interferon and viral shedding prevention dur-
ing innate response to infections (LY6) [108, 109].
Tumor necrosis factor (TNF) and LTA are pro-
inflammatory cytokines classified to the GO BP “apop-
totic process” (GO:0006915). Polymorphisms in TNF
have been reported to contribute partially to the develop-
ment of lymphosarcoma and PVL in BLV infected cattle
[30, 110] and early elimination of BLV in experimentally
infected sheep [111].
Several of the targeted genomic regions in the GWAS
might be involved in viral intra-host spreading after pri-
mary infection according to mechanisms proposed in [81].
For example, in the case of cells-cells fusions the SNP
rs110473048 (pPVL = 1.78 × 10
− 12 and pWBC = 9.97 × 10
− 08)
is at 7.21 kb from the Transcription Factor (TF) GCM1
(Glial Cells Missing 1) gene that regulates the expres-
sion of the ENV gene (located in the endogenous retro-
virus HERV-W) [112] encoding for a fusogenic protein
called Syncytin-1. Recently, it has been postulated that
infection by an exogenous virus can trans activate
ENV ectopically by increasing the expression of GCM1
[113] and promoting syncytia formation in breast can-
cer and endometrial carcinoma [114, 115].
Two significantly associated SNPs mapped within and
close to TRAM2 (Translocation-Associated Membrane
Protein 2) gene, involved in the biosynthesis and excre-
tion of type I collagen [116] that constitutes the extracel-
lular matrix components [117] where virions are stored.
The SNP rs109343703 causes an intronic substitution
and the rs110499907 SNP is located 24.7 kb upstream of
it. Both SNPs were associated with PVL and not with
WBCs, and the nearest SNP in BoLA-DRB3 was in
strong LD (r2 > 0.85) with them. Another associated
polymorphism (rs110836188) produces a synonymous
substitution in the TNXB gene (Tenascin-X), which en-
codes an extracellular matrix protein involved in matrix-
cell adhesion (GO:0007160) and organization of collagen
fibres (GO:0030199). Ultimately, analogous to “immuno-
logical synapses” some viruses subvert cellular processes
to disseminate in the host through “virological synapses”
[118, 119]. In this process, cytoskeletal proteins are required
for polarization of cells involved in the synapses [120, 121].
Crucially, the SNP rs110155623 associated with both pheno-
types is located in the putative regulatory region of CD2AP
(CD2-associated protein). CD2AP organizes the cytoskel-
eton in polarization sites (GO:2,000,249) interacting dir-
ectly with the Actin protein [122]. Two other GWAS
hit variants could capture the effects of genes related to
regulation and polymerization of the cytoskeleton
structures. A substitution in an intron in the polycystic
kidney and hepatic disease 1 (PKHD1) gene (rs41641297)
and a SNP (rs110742604) positioned in regulatory regions
of TUBB5 and FLOT1 genes. The TUBB5 gene encodes
β5-tubulin which belongs to the β-tubulin family.
Finally, four SNPs were assigned to TFs (Table 2) regulat-
ing transcriptional processes in promoters depending on
RNA polymerase II (GO:0006357). TF genes are candidates
for host determinants controlling BLV intra−host spread-
ing, due to a tight mechanism of transcriptional regulation
exerted by the trans-activating protein Tax, modulating sev-
eral host signalling pathways such as AP-1, NF-κB and
CREB to induce oncogenic transformation [123].
Altogether, in addition to classical immune response re-
lated genes, in this study we pointed novel genes/mecha-
nisms as possibly involved in PVL control and hence BLV
dissemination.
Despite our results do not conclusively identify causal
genomic variants; we have successfully contracted the
landscape of genes potentially related to BLV infections
to a short list of very specific candidate genes suitable
for experimental validations by gene-expression assays.
These results also encourage fine mapping and valid-
ation studies. Furthermore, functional studies integrating
multi-omics data will allow discerning the underlying
molecular mechanisms of the BLV−host interaction.
Conclusions
Results obtained in this study revealed relevant genetic vari-
ants in the bovine MHC strongly influencing the control of
BLV infection in cattle. Functional inspection of genes har-
bouring statistically significant associated SNPs brought
preliminary evidence about possible biological pathways
underlying the LI in infected cows. The proviral BLV load
is associated with the stage of the disease progression in the
infected cows and directly determines its ability to transmit
BLV to healthy animals. Therefore, genome wide identifica-
tion of genetics variants associated with low proviral load
BLV infections would be useful not only to design thera-
peutics and preventive treatments but also as alternative
control programs based on selective breeding of animals
through genomic selection in dairy cattle.
Additional files
Additional file 1: Figure S1. Pedigree of the Holstein and Jersey
crosses cattle population under study. Red lines connect the individual
with his father. Blue lines connect the individual with his mother.
(DOCX 252 kb).
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Additional file 2: Figure S2. Holstein and Jersey crosses population
sub-structure. Each point represents the coordinates of PC1 and PC2 for
each individual. The assignment of PCs allowed inferences about the
ancestry origin of cows. (0; 12.5; 25; 50; 75 and 100 of Holstein breed
percentage). (DOCX 236 kb).
Additional file 3: Figure S3. QQ plots and genome inflation factor (λ)
in GWAS with PVL. The p-values come from a logistic regression under an
additive model of association of SNPs with the level of PVL. The genomic
inflation factor quantifies the volume of inflation observed. A) A strong
deviation in the -log10(p) (black circle) from the line of identity (red line)
was observed without considering covariates, λ= 5.31. B) A small adjustment
was observed when included the following covariates: Age of the animal (A),
Herd (H), Number of lactation (L) Percentage of Holstein (PH) and Bull
(B), λ = 4.07. C) A significant correction is manifested including the first
8 Principal Components (PC1-PC8), λ = 1.26. D) When considering all
the covariates together, the correction level approaches the CI95% of
the null distribution (dotted lines), λ = 1.21. (DOCX 404 kb).
Additional file 4: Figure S4. QQ plots and genome inflation factor (λ)
in GWAS with WBC counts. Analyses were based on the -log10(p) from
logistic regression under an additive model of association of SNPs with
WBCs. A) A pronounced deviation from the null distribution (red line) is
manifested in the model without covariates, λ = 3.99. B) When covariates
A_DF_L_PH_B were adjusted in the model λ decreases to 2.76, C) A
significant correction is achieved by considering PC1-PC8, λ = 1.31. D)
When considering all the covariates together (PC1-PC8_A_H_L_PH_B) the
correction level approached the CI 95% of the null distribution (dotted
lines), λ = 1.30. (DOCX 429 kb)
Additional file 5: Table S1. Top 15 SNPs with the lowers p-value from
the GWA analysis with PVL excluding SNPs located ~ 20–36 Mb of BTA 23
(DOCX 20 kb).
Additional file 6: Figure S5. LD decay by distance. LD measures were
considered among syntenic SNPs pairs separated < 1 Mb. The r2 values
were averaged each 10 Kb and plotted versus inter-SNPs distances.
(DOCX 56 kb).
Additional file 7: Table S2. Description of PC categories identified and
genes containing them. (DOCX 22 kb).
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